你即將離開本站

並前往https://www.biospace.com/article/releases/inbuild-meets-primary-endpoint-study-evaluated-ofev-in-patients-across-a-range-of-progressive-fibrosing-interstitial-lung-diseases/

INBUILD® meets primary endpoint: study evaluated Ofev® in ...

In the INBUILD trial, nintedanib slowed lung function decline by 57% across the overall study population, with an adjusted annual rate of ...

確定！ 回上一頁

查詢 「INBUILD trial」的人也找了：

  1. INBUILD trial
    2.
  2. SENSCIS trial
    3.
  3. Nintedanib clinical trial
    4.
  4. pf-ild definition
    5.
  5. Pirfenidone
    6.
  6. TOMORROW trial
    7.
  7. RELIEF pirfenidone
    8.
  8. Progressive fibrosing interstitial lung disease
    9.